Institutional Ownership Moon Lake Immunotherapeutics (MLTX)
This table provides information about the institutional ownership of Moon Lake Immunotherapeutics (MLTX). We have compiled data on the 157 institutions that hold shares in the stock, with a total of 54.8 Million shares, which have been reported (via 13F filing form) to have a value of $3.04 Billion.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Bvf Inc
San Francisco, CA |
Aug 14, 2025 Q2 2025 |
19,751,284
shares
|
$1.09 Billion
36.63% of portfolio
|
Q4 2024
Reduced 9.19%
|
|
|
Cormorant Asset Management, LP
Boston, MA |
Aug 14, 2025 Q2 2025 |
8,494,151
shares
|
$470 Million
40.43% of portfolio
|
Q4 2023
Added 4.32%
|
|
|
Avoro Capital Advisors LLC
New York, NY |
Aug 14, 2025 Q2 2025 |
4,150,000
shares
|
$230 Million
3.57% of portfolio
|
Q2 2025
Added 49.81%
|
|
|
Price T Rowe Associates Inc
Baltimore, MD |
Aug 14, 2025 Q2 2025 |
2,613,233
shares
|
$145 Million
0.01% of portfolio
|
Q2 2025
Reduced 12.13%
|
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
Aug 14, 2025 Q2 2025 |
1,674,041
shares
|
$92.7 Million
0.01% of portfolio
|
Q2 2025
Added 13.22%
|
|
|
Westfield Capital Management CO LP
Boston, MA |
May 09, 2025 Q1 2025 |
1,434,770
shares
|
$79.4 Million
0.29% of portfolio
|
Q1 2025
Added 9.39%
|
|
|
Goldman Sachs Group Inc
New York, NY |
Aug 14, 2025 Q2 2025 |
1,275,569
shares
|
$70.6 Million
0.01% of portfolio
|
Q2 2025
Reduced 1.32%
|
|
|
Federated Hermes, Inc.
Pittsburgh, PA |
Aug 13, 2025 Q2 2025 |
1,248,573
shares
|
$69.1 Million
0.12% of portfolio
|
Q2 2025
Reduced 1.64%
|
|
|
Alliancebernstein L.P.
New York, NY |
Aug 14, 2025 Q2 2025 |
1,138,022
shares
|
$63 Million
0.02% of portfolio
|
Q2 2025
Added 17.8%
|
|
|
Pictet Asset Management Sa
Geneva 73, V8 |
Aug 10, 2023 Q2 2023 |
894,005
shares
|
$49.5 Million
0.05% of portfolio
|
Q2 2023
New holding
|
|
|
Paradigm Biocapital Advisors LP
New York, NY |
Aug 14, 2025 Q2 2025 |
878,323
shares
|
$48.6 Million
1.94% of portfolio
|
Q2 2025
Added 39.99%
|
|
|
Nuveen, LLC
Charlotte, NC |
Aug 12, 2025 Q2 2025 |
791,555
shares
|
$43.8 Million
0.01% of portfolio
|
Q2 2025
Added 17.56%
|
|
|
Rtw Investments, LP
New York, NY |
Aug 14, 2025 Q2 2025 |
741,090
shares
|
$41 Million
0.54% of portfolio
|
Q2 2025
New holding
|
|
|
Hood River Capital Management LLC
Palm Beach Gardens, FL |
Aug 14, 2025 Q2 2025 |
675,445
shares
|
$37.4 Million
0.51% of portfolio
|
Q2 2025
Added 1.88%
|
|
|
Nuveen Asset Management, LLC
Chicago, IL |
Feb 14, 2025 Q4 2024 |
595,581
shares
|
$33 Million
0.01% of portfolio
|
Q4 2024
Added 2.55%
|
|
|
Vestal Point Capital, LP
New York, NY |
Aug 14, 2025 Q2 2025 |
550,000
shares
|
$30.4 Million
1.37% of portfolio
|
Q2 2025
Added 175.0%
|
|
|
Marshall Wace, LLP
London, X0 |
Aug 13, 2025 Q2 2025 |
529,211
shares
|
$29.3 Million
0.03% of portfolio
|
Q2 2025
Reduced 17.43%
|
|
|
Siren, L.L.C.
New York, NY |
Aug 13, 2025 Q2 2025 |
508,267
shares
|
$28.1 Million
1.24% of portfolio
|
Q2 2025
New holding
|
|
|
Balyasny Asset Management LLC
Chicago, IL |
Aug 14, 2025 Q2 2025 |
423,170
shares
|
$23.4 Million
0.03% of portfolio
|
Q2 2025
Added 436.78%
|
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
392,024
shares
|
$21.7 Million
0.0% of portfolio
|
Q2 2024
Reduced 3.98%
|
|
|
Bio Impact Capital LLC
Cambridge, MA |
Aug 14, 2025 Q2 2025 |
313,571
shares
|
$17.4 Million
2.9% of portfolio
|
Q2 2025
Reduced 0.78%
|
|
|
Woodline Partners LP
San Francisco, CA |
Aug 14, 2025 Q2 2025 |
310,602
shares
|
$17.2 Million
0.08% of portfolio
|
Q2 2025
Added 4.88%
|
|
|
Fred Alger Management, LLC
New York, NY |
Aug 14, 2025 Q2 2025 |
295,623
shares
|
$16.4 Million
0.07% of portfolio
|
Q2 2025
Reduced 54.02%
|
|
|
Saturn V Capital Management LLC
Austin, TX |
Aug 13, 2025 Q2 2025 |
290,784
shares
|
$16.1 Million
5.56% of portfolio
|
Q2 2025
Reduced 15.43%
|
|
|
5 Am Venture Management, LLC
San Francisco, CA |
Aug 14, 2025 Q2 2025 |
282,313
shares
|
$15.6 Million
8.94% of portfolio
|
Q1 2024
Reduced 6.71%
|